LCI Medical is a device company with production lines in France and Tunisia, and serves as a supplier to Safe Orthopaedics.
The company reported a turnover of $2.81 million dollars in 2019, with Safe Orthopaedics covering more than 30 percent of LCI Medical’s turnover.
The acquisition will allow Safe Orthopaedics to incorporate the entire production value chain — conception, technology, production, distribution and hospital services — into its operations and open the door for new growth opportunities and partnerships in the orthopedic field.
Editor’s note: This article converted LCI Medical’s 2019 turnover from euro to U.S. dollars using market exchange rates on May 6.
More articles on devices:
AAOS offers patients guidance on managing orthopedic care during COVID-19
Johnson & Johnson pays $3.9M for allegedly misrepresenting hip products, surgical mesh
Florida orthopedic practice ‘thrilled’ to resume elective surgeries
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
